108 related articles for article (PubMed ID: 30072192)
1. Are Providers and Patients Following Hormonal Therapy Guidelines for Patients Over the Age of 70? The Influence of CALGB 9343.
Cortina CS; Agarwal S; Mulder LL; Poirier J; Rao R; Ansell DA; Madrigrano A
Clin Breast Cancer; 2018 Dec; 18(6):e1289-e1292. PubMed ID: 30072192
[TBL] [Abstract][Full Text] [Related]
2. Impact of CALGB 9343 Trial and Sociodemographic Variation on Patterns of Adjuvant Radiation Therapy Practice for Elderly Women (≥70 Years) with Stage I, Estrogen Receptor-positive Breast Cancer: Analysis of the National Cancer Data Base.
Chu QD; Zhou M; Medeiros KL; Peddi P; Wu XC
Anticancer Res; 2017 Oct; 37(10):5585-5594. PubMed ID: 28982874
[TBL] [Abstract][Full Text] [Related]
3. The use of adjuvant radiotherapy in elderly patients with early-stage breast cancer: changes in practice patterns after publication of Cancer and Leukemia Group B 9343.
Palta M; Palta P; Bhavsar NA; Horton JK; Blitzblau RC
Cancer; 2015 Jan; 121(2):188-93. PubMed ID: 25488523
[TBL] [Abstract][Full Text] [Related]
4. Radiotherapy Utilization for Patients Over Age 60 With Early Stage Breast Cancer.
Paulsson AK; Fowble B; Lazar AA; Park C; Sherertz T
Clin Breast Cancer; 2020 Apr; 20(2):168-173. PubMed ID: 31744755
[TBL] [Abstract][Full Text] [Related]
5. Long-term Impact of CALGB 9343 on Radiation Utilization.
Squeo G; Malpass JK; Meneveau M; Balkrishnan R; Desai RP; Lattimore C; Anderson RT; Showalter SL
J Surg Res; 2020 Dec; 256():577-583. PubMed ID: 32805580
[TBL] [Abstract][Full Text] [Related]
6. Real-world patterns of endocrine therapy for metastatic hormone-receptor-positive (HR+)/human epidermal growth factor receptor-2-negative (HER2-) breast cancer patients in the United States: 2002-2012.
Swallow E; Zhang J; Thomason D; Tan RD; Kageleiry A; Signorovitch J
Curr Med Res Opin; 2014 Aug; 30(8):1537-45. PubMed ID: 24669852
[TBL] [Abstract][Full Text] [Related]
7. The Use of Hormone Therapy Alone Versus Hormone Therapy and Radiation Therapy for Breast Cancer in Elderly Women: A Population-Based Study.
Nichol AM; Chan EK; Lucas S; Smith SL; Gondara L; Speers C; Tyldesley S
Int J Radiat Oncol Biol Phys; 2017 Jul; 98(4):829-839. PubMed ID: 28602413
[TBL] [Abstract][Full Text] [Related]
8. Eligibility, compliance and persistence of extended adjuvant endocrine therapy for breast cancer.
Myrick ME; Schmid SM; Kilic N; Güth U
Acta Oncol; 2012 Feb; 51(2):247-53. PubMed ID: 21985132
[TBL] [Abstract][Full Text] [Related]
9. Omitting radiotherapy in women ≥ 65 years with low-risk early breast cancer after breast-conserving surgery and adjuvant endocrine therapy is safe.
Wickberg Å; Liljegren G; Killander F; Lindman H; Bjöhle J; Carlberg M; Blomqvist C; Ahlgren J; Villman K
Eur J Surg Oncol; 2018 Jul; 44(7):951-956. PubMed ID: 29709338
[TBL] [Abstract][Full Text] [Related]
10. High non-compliance in the use of letrozole after 2.5 years of extended adjuvant endocrine therapy. Results from the IDEAL randomized trial.
Fontein DB; Nortier JW; Liefers GJ; Putter H; Meershoek-Klein Kranenbarg E; van den Bosch J; Maartense E; Rutgers EJ; van de Velde CJ
Eur J Surg Oncol; 2012 Feb; 38(2):110-7. PubMed ID: 22172646
[TBL] [Abstract][Full Text] [Related]
11. Prescribing practices of endocrine therapy for ductal carcinoma
Chaudhry AT; Koulis TA; Speers C; Olson RA
Curr Oncol; 2018 Apr; 25(2):133-138. PubMed ID: 29719429
[TBL] [Abstract][Full Text] [Related]
12. Omission of chemotherapy for low-grade, luminal A N1 breast cancer: Patterns of care and clinical outcomes.
Haque W; Verma V; Hatch S; Klimberg VS; Butler EB; Teh BS
Breast; 2018 Oct; 41():67-73. PubMed ID: 30007270
[TBL] [Abstract][Full Text] [Related]
13. Comparison of Adjuvant Radiation Therapy Alone Versus Radiation Therapy and Endocrine Therapy in Elderly Women With Early-Stage, Hormone Receptor-Positive Breast Cancer Treated With Breast-Conserving Surgery.
Murphy CT; Li T; Wang LS; Obeid EI; Bleicher RJ; Eastwick G; Johnson ME; Hayes SB; Weiss SE; Anderson PR
Clin Breast Cancer; 2015 Oct; 15(5):381-9. PubMed ID: 25861716
[TBL] [Abstract][Full Text] [Related]
14. Adjuvant tamoxifen prescription in women 65 years and older with primary breast cancer.
Silliman RA; Guadagnoli E; Rakowski W; Landrum MB; Lash TL; Wolf R; Fink A; Ganz PA; Gurwitz J; Borbas C; Mor V
J Clin Oncol; 2002 Jun; 20(11):2680-8. PubMed ID: 12039930
[TBL] [Abstract][Full Text] [Related]
15. Impact of guideline changes on use or omission of radiation in the elderly with early breast cancer: practice patterns at National Comprehensive Cancer Network institutions.
McCormick B; Ottesen RA; Hughes ME; Javid SH; Khan SA; Mortimer J; Niland JC; Weeks JC; Edge SB
J Am Coll Surg; 2014 Oct; 219(4):796-802. PubMed ID: 25127504
[TBL] [Abstract][Full Text] [Related]
16. Five versus more than five years of tamoxifen therapy for breast cancer patients with negative lymph nodes and estrogen receptor-positive tumors.
Fisher B; Dignam J; Bryant J; DeCillis A; Wickerham DL; Wolmark N; Costantino J; Redmond C; Fisher ER; Bowman DM; Deschênes L; Dimitrov NV; Margolese RG; Robidoux A; Shibata H; Terz J; Paterson AH; Feldman MI; Farrar W; Evans J; Lickley HL
J Natl Cancer Inst; 1996 Nov; 88(21):1529-42. PubMed ID: 8901851
[TBL] [Abstract][Full Text] [Related]
17. Initial Trends in the Use of the 21-Gene Recurrence Score Assay for Patients With Breast Cancer in the Medicare Population, 2005-2009.
Dinan MA; Mi X; Reed SD; Hirsch BR; Lyman GH; Curtis LH
JAMA Oncol; 2015 May; 1(2):158-66. PubMed ID: 26181015
[TBL] [Abstract][Full Text] [Related]
18. Evaluating Candidacy for Hypofractionated Radiation Therapy, Accelerated Partial Breast Irradiation, and Endocrine Therapy After Breast Conserving Surgery: A Surveillance Epidemiology and End Results (SEER) Analysis.
Manyam BV; Tendulkar R; Cherian S; Vicini F; Badiyan SN; Shah C
Am J Clin Oncol; 2018 Jun; 41(6):526-531. PubMed ID: 27635622
[TBL] [Abstract][Full Text] [Related]
19. Community-based use of chemotherapy and hormonal therapy for early-stage breast cancer: 1987-2000.
Harlan LC; Clegg LX; Abrams J; Stevens JL; Ballard-Barbash R
J Clin Oncol; 2006 Feb; 24(6):872-7. PubMed ID: 16484696
[TBL] [Abstract][Full Text] [Related]
20. Breast cancer update.
Kuter I
Oncologist; 2000; 5(4):285-92. PubMed ID: 10964995
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
